CAPUCCI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 6.955
EU - Europa 3.471
AS - Asia 2.321
SA - Sud America 701
AF - Africa 283
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 13.749
Nazione #
US - Stati Uniti d'America 6.888
SG - Singapore 930
UA - Ucraina 666
BR - Brasile 594
CN - Cina 474
IT - Italia 438
RU - Federazione Russa 431
DE - Germania 420
IE - Irlanda 398
SE - Svezia 298
DK - Danimarca 220
HK - Hong Kong 220
VN - Vietnam 194
TR - Turchia 181
GB - Regno Unito 172
FI - Finlandia 161
MA - Marocco 143
KR - Corea 116
FR - Francia 111
CI - Costa d'Avorio 98
IN - India 65
AR - Argentina 45
CA - Canada 39
NL - Olanda 33
PL - Polonia 28
ES - Italia 26
EC - Ecuador 25
BD - Bangladesh 24
JP - Giappone 24
MX - Messico 20
IQ - Iraq 19
BE - Belgio 18
AT - Austria 16
ZA - Sudafrica 16
ID - Indonesia 13
EU - Europa 12
CZ - Repubblica Ceca 11
EG - Egitto 10
CO - Colombia 9
JO - Giordania 7
KZ - Kazakistan 7
PK - Pakistan 7
RO - Romania 7
TN - Tunisia 7
UZ - Uzbekistan 7
VE - Venezuela 7
PE - Perù 6
RS - Serbia 6
CL - Cile 5
PY - Paraguay 5
AU - Australia 4
LB - Libano 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
IL - Israele 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SR - Suriname 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 13.749
Città #
Jacksonville 708
Ashburn 681
Chandler 664
Singapore 586
Fairfield 556
Dublin 394
Boardman 371
Dallas 325
New York 301
Wilmington 245
Hong Kong 215
Seattle 213
Woodbridge 212
Houston 200
Cambridge 182
Lawrence 149
Princeton 149
Beijing 144
San Mateo 144
Ann Arbor 115
Los Angeles 113
Abidjan 98
The Dalles 94
Hefei 90
Des Moines 83
Munich 74
San Diego 73
Moscow 67
Ho Chi Minh City 61
São Paulo 56
Turin 53
London 49
Hanoi 46
Ancona 44
Chicago 43
Centro 39
Buffalo 38
Turku 34
Pune 30
Warsaw 24
Santa Clara 23
Tokyo 23
Frankfurt am Main 21
Norwalk 21
Salt Lake City 20
Washington 20
Belo Horizonte 18
Rio de Janeiro 18
Brussels 17
Helsinki 17
Nuremberg 16
Atlanta 15
Chennai 15
Denver 15
Montreal 15
Orem 15
Poplar 15
Stockholm 15
Amsterdam 14
Guangzhou 14
Porto 14
Shanghai 14
Brasília 13
Johannesburg 13
Phoenix 12
Salvador 12
Redmond 11
Rome 10
Baghdad 9
Da Nang 9
Guayaquil 9
Manchester 9
Olomouc 9
Tampa 9
Vienna 9
Wuhan 9
Campinas 8
Cavallermaggiore 8
Columbus 8
Curitiba 8
Elk Grove Village 8
Macerata 8
Amman 7
Biên Hòa 7
Boston 7
Brooklyn 7
Cairo 7
Hải Dương 7
Kazan' 7
Kilburn 7
Lancaster 7
Mexico City 7
Milan 7
Pesaro 7
Porto Alegre 7
Quito 7
Ankara 6
Campo Grande 6
Chiswick 6
City of London 6
Totale 8.451
Nome #
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. 196
Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients with Takotsubo Syndrome 177
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 162
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 158
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 146
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 139
An Unusual Left Atrial Mass in a Woman with Active Breast Cancer and Recent Cardiothoracic Surgery 128
Tachycardiomyopathy in Patients without Underlying Structural Heart Disease 125
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? 119
Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD) 116
Flecainide: Electrophysiological properties, clinical indications, and practical aspects 116
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 115
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 115
Amiodarone and digitalis: An odd couple in a tachycardiomyopathic patient 114
New anthyarrhythmic drugs for atrial fibrillation 114
Coronary Spasm and Inflammation: Can We Kill 2 Birds With 1 Stone? 114
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 113
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 112
Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. 111
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 111
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. 110
Takotsubo syndrome in the paediatric population: A case report and a systematic review 108
Comorbidities frequency in takotsubo syndrome: An international collaborative systematic review including 1109 patients 107
A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I 107
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. 106
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 103
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 103
Clinically guided pacemaker choice and setting: pacemaker expert programming study 100
Atrial Fibrillation and Congestive Heart Failure: should we aim to control the heart's rate or its rhythm? 99
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. 99
Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry 99
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD) 99
Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. 98
Letter by Ciliberti and Capucci regarding article, "medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease" 98
Subclinical atrial fibrillation and the risk of stroke 97
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis 97
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation 97
Antiarrhythmic drugs for atrial fibrillation. 97
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 96
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation. 96
Dr. Guerra, et al reply 96
Temporal relationship between subclinical atrial fibrillation and embolic events 96
Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments 95
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. 94
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 94
Cardioembolism and takotsubo syndrome: A case report 94
The ECG in the differential diagnosis between takotsubo cardiomyopathy and acute coronary syndrome 94
Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation 94
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 94
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. 93
[Early and mid-term results of the transapical aortic valve Symetis Acurate TA: a viable solution in high-risk patients with severe vascular disease] 93
Is there an 'atherosclerotic continuum' from angina with unobstructed coronary arteries to MINOCA? 93
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. 92
Hospitalization in ICD recipients. 92
Transient QRS amplitude attenuation is associated with clinical recovery in patients with takotsubo cardiomyopathy 92
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). 91
Cardiomyopathy induced by frequent premature ventricular complexes originating from the right ventricular outflow tract: left ventricular systolic function recovery after transcatheter ablation. 91
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 91
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. 91
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. 90
Dronedarone: a real innovation or a mere second-best choice? How to find the way among guidelines, regulatory agencies and daily clinical practice 90
Current Therapeutic Options for Heart Failure in Elderly Patients 89
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. 88
Is invasive coronary provocation testing cost-effective among MINOCA patients? 88
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy 88
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. 88
Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age 87
Out-of-hospital cardiac arrest and public access defibrillation. 87
Temporal trends and temperature-related incidence of electrical storm: The TEMPEST Study (Temperature-related incidence of electrical storm) 87
Global Longitudinal Strain as a Predictor of First and Subsequent Arrhythmic Events in Remotely Monitored ICD Patients With Structural Heart Disease 87
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 86
Endocardial defibrillation lead extraction: an unusual case of entrapment. 86
The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's. 86
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients 86
Memorizzazione a distanza dei contenuti teorici derivati dai corsi BLS e BLS-D 86
Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. 86
Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis 85
Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis 85
Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). 85
Sedation in cardiac arrhythmias management 85
Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring 84
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry 84
Indications for implantable cardioverter defibrillator (ICD) therapy. 83
Rebuttal of critique of Progetto Vita survival data 83
Far-field R wave oversensing in dual chamber pacemakers designed for atrial arrhythmia management: effect of pacing site and lead tip to ring distance. 82
Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: A randomized, open-blinded, prospective study 82
Capture of atrial fibrillation reduces the atrial defibrillation threshold. 81
Racial and Ethnic Differences in Electrocardiographic Features of Takotsubo Cardiomyopathy 81
Emerging pharmacotherapies for the treatment of atrial fibrillation 81
To the Editor— Flecainide and propafenone: Good twins for premature ventricular contractions’ killing but not exactly superimposable 81
Entirely Subcutaneous Implantable Defibrillator: Safest Option in a Young Girl With Ventricular Tachycardia and Ebstein Anomaly 81
ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 80
Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet? 79
Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study 79
Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. 79
Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents 78
Symptomatic atrial fibrillation and risk of cardiovascular events: Data from the Euro Heart Survey 78
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 78
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. 77
Electrical storm and heart failure worsening in implantable cardiac defibrillator patients 77
Totale 9.820
Categoria #
all - tutte 80.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.203 0 0 0 0 0 148 233 141 197 184 208 92
2021/20221.106 89 287 33 25 28 48 73 68 66 71 121 197
2022/20232.113 175 223 146 168 161 281 7 106 469 46 254 77
2023/20241.346 254 48 97 186 233 297 18 36 12 24 15 126
2024/20252.382 191 330 104 18 74 61 128 94 579 167 263 373
2025/20263.002 458 389 385 868 635 267 0 0 0 0 0 0
Totale 13.979